Skip to main content

Advertisement

Fig. 1 | BMC Nephrology

Fig. 1

From: Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study

Fig. 1

Study population selection from the United States Renal Data System. We selected a cohort of adult patients initiating peritoneal dialysis between 2007 and 2011 in the U.S. with DaVita, Inc. who survived to day 90 of dialysis with residual renal function (24-h urine volume ≥ 200 ml), and who had continuous Medicare Parts A, B, and D coverage from day 1 to 90. ESRD – end-stage renal disease

Back to article page